banner
Bcr-Abl inhibitor Radotinib, Purity ≥98%
Inquiry

Cat. No.: X24-06-ZQ522

Bcr-Abl inhibitor Radotinib, Purity ≥98%

Synonym: 926037-48-1; Bcr-Abl inhibitor; IY-5511

  • MDL: MFCD27956910
  • CAS Number: 926037-48-1
  • Compound CID: 16063245
img
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Radotinib, soluble in DMSO and insoluble in ethanol and water, specifically inhibits the activity of the Bcr-Abl tyrosine kinase. It targets BCR-ABL1.
Molecular Weight
530.5
Molecular Formula
C27H21F3N8O
Targets
BCR-ABL1: 34 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 94 mg/mL (177.19 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Radotinib is explored for its ability to inhibit Bcr-Abl kinase, offering insights into therapeutic approaches for chronic myeloid leukemia.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0